JP2024526939A5 - - Google Patents

Info

Publication number
JP2024526939A5
JP2024526939A5 JP2024503840A JP2024503840A JP2024526939A5 JP 2024526939 A5 JP2024526939 A5 JP 2024526939A5 JP 2024503840 A JP2024503840 A JP 2024503840A JP 2024503840 A JP2024503840 A JP 2024503840A JP 2024526939 A5 JP2024526939 A5 JP 2024526939A5
Authority
JP
Japan
Application number
JP2024503840A
Other languages
Japanese (ja)
Other versions
JPWO2023004151A5 (https=
JP2024526939A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/038072 external-priority patent/WO2023004151A1/en
Publication of JP2024526939A publication Critical patent/JP2024526939A/ja
Publication of JPWO2023004151A5 publication Critical patent/JPWO2023004151A5/ja
Publication of JP2024526939A5 publication Critical patent/JP2024526939A5/ja
Pending legal-status Critical Current

Links

JP2024503840A 2021-07-22 2022-07-22 酸化的網膜疾患の進行を抑制する方法 Pending JP2024526939A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202163224690P 2021-07-22 2021-07-22
US202163224679P 2021-07-22 2021-07-22
US202163224674P 2021-07-22 2021-07-22
US63/224,679 2021-07-22
US63/224,690 2021-07-22
US63/224,674 2021-07-22
PCT/US2022/038072 WO2023004151A1 (en) 2021-07-22 2022-07-22 Methods for inhibiting the progression of oxidative retinal diseases

Publications (3)

Publication Number Publication Date
JP2024526939A JP2024526939A (ja) 2024-07-19
JPWO2023004151A5 JPWO2023004151A5 (https=) 2024-07-29
JP2024526939A5 true JP2024526939A5 (https=) 2024-07-29

Family

ID=84979648

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024503840A Pending JP2024526939A (ja) 2021-07-22 2022-07-22 酸化的網膜疾患の進行を抑制する方法

Country Status (8)

Country Link
US (1) US20250099415A1 (https=)
EP (1) EP4373479A4 (https=)
JP (1) JP2024526939A (https=)
KR (1) KR20240036651A (https=)
AU (1) AU2022313207A1 (https=)
CA (1) CA3227139A1 (https=)
IL (1) IL310210A (https=)
WO (1) WO2023004151A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024049497A1 (en) * 2022-09-02 2024-03-07 Biojiva Llc Pharmaceutical compositions of d10-docosahexaenoic acid or esters thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060270739A1 (en) * 2005-04-28 2006-11-30 Trustees Of Tufts College Synergistic effects of docosahexaenoic acid (DHA) and carotenoid absorption on macular pigmentation
CA2723139A1 (en) * 2007-07-30 2009-02-05 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Dha and pedf, a therapeutic composition for nerve and retinal pigment epithelial cells
WO2009058815A2 (en) * 2007-10-29 2009-05-07 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Lipoxin a4 protection for retinal cells
EP3689342A1 (en) * 2011-04-26 2020-08-05 Retrotope, Inc. Oxidative retinal diseases
CA3005983A1 (en) * 2015-11-23 2017-06-01 Retrotope, Inc. Site-specific isotopic labeling of 1,4-diene systems
CA3117216A1 (en) * 2018-11-15 2020-05-22 Retrotope, Inc. Deuterated compounds, compositions, and uses

Similar Documents

Publication Publication Date Title
BR102022025291A2 (https=)
JP2024526939A5 (https=)
CL2026000295A1 (es) Membranas adsorbentes a base de salicilaldoxima de imidazol de zinc para capturar iones metálicos.
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
BY13168U (https=)
CN307045513S (https=)
BY13174U (https=)
BY13172U (https=)
BY13176U (https=)
BY13170U (https=)
BY13169U (https=)
BY13141U (https=)